A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males
Clinical trial NCT07630233 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07630233
- Sponsor
- The United Bio-Technology (Hengqin) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-19
- Primary completion
- 2026-10-25
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.